Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

81 results about "Conceptus" patented technology

Conceptus (Latin: conceptio, meaning derivatives of zygote) denotes the embryo and its adnexa (appendages or adjunct parts) or associated membranes (i.e. the products of conception). The conceptus includes all structures that develop from the zygote, both embryonic and extraembryonic. It includes the embryo as well as the embryonic part of the placenta and its associated membranes - amnion, chorion (gestational sac), and yolk sac.

Embryoid Body - Based Screen

Disclosed are embryoid bodies having a uniform size of approximately 415 nm and comprising genetically modified embryonic stem cells, and methods of making same. The genetically uniform embryoid bodies can be multiplexed as one embryoid body per well in a multiwell format, and used as a high to medium throughput screen for test agents that affect the development and homeostasis of animals, including humans. The genetic modification of the embryonic stem cells is a promoter-report-selection construct that enables the selection and detection of cells of a particular lineage in the EB, to determine the effects of a test agent.
Owner:GENEPROTECH

Methods and compositions for vaccination of poultry

The present invention provides methods of inducing an immune response against Clostridium species in birds, for protecting birds from Clostridium infection, and / or for protecting birds from related disorders such as necrotic enteritis. The methods can be practiced in ovo and / or post-hatch. The invention further provides compositions and methods for delivery of a composition of this invention in ovo directly to the embryo body.
Owner:EMBREX INC

Extracellular matrix gel model used for researching development and differentiation of embryonic stem cells

The invention relates to an extracellular matrix gel model used for researching development and differentiation of embryonic stem cells, belonging to the research field of tissue engineering and regenerative medicine, and mainly solving the problem that no ideal model exists for the research of differentiation and development of embryonic stem cells in vitro. We the extracellular matrix gel adopt as the in vitro three dimensional model of the differentiation and development of embryonic stem cells, inoculate the embryonic stem cells to the three dimensional model in different cell densities, and observe the phenomena of the forming of embryoid body by self-differentiation of the embryonic stem cells and the law of the embryoid body being differentiated into cells of different ancestries; and the microenvironment in which the embryonic stem cells grow is regulated, the extracellular matrix gel is taken as the main body to carry out the directional differentiation and development research of the embryonic stem cells, thus disclosing the inherent law and mechanism of the in vitro differentiation and development of the embryonic stem cells, and searching for new methods for directional differentiation of embryonic stem cells to the functional cells of important vital organs at the terminal differentiation period; and the invention will provide a new technical method for exploring the development mechanism of the embryonic stem cells.
Owner:INST OF BASIC MEDICAL SCI ACAD OF MILITARY MEDICAL SCI OF PLA

Method for differentiation of embryonic stem cells into nerve cells through in vitro induction

The invention belongs to the field of biomedicine, and relates to a method for differentiation of embryonic stem cells into nerve cells through in vitro induction, especially to a method for induction of Olig2<+>-GFP<+>-mES nerve cell differentiation through a purine derivative Purmorphamine, and uses thereof. According to the present invention, an embryoid body mediated nerve induction method is adopted, Olig2-GFP<+>-mES is adopted as a cell model, a purine derivative Purmorphamine and all-trans retinoic acid are combined to carry out directed induction on the Olig2-GFP<+>-mES cells to obtain spinal motor neurons and oligodendrocyte progenitor cells through differentiation; experiment results show that the Purmorphamine can be used as a substitute of SHH, can effectively induce Olig2<+>-GFP<+>-mES differentiation to obtain high purity and function spinal motor neurons and oligodendroglial cells, and can cause expression changes of related genes; and transplant experiment results show that the induced nerve cells can promote partial function and morphology restoration after rat spinal cord injury, and have effects of spinal cord injury regeneration promotion and function reconstruction.
Owner:FUDAN UNIV

Method for creating hepatocyte by human embryo stem cell external evoked differentiation

The present invention provides a method that embryo of human embryonic stem cells (HES) is directionally induced and divided into liver cells. First, the biological property of high degree of self-regeneration multiplication of HES cell is made use of, the collagenase IV digestion is adopted for transfer of culture and augmentation, thereby obtaining a plurality of stem cells; second, the HES cell is inoculated into a cell utensil with lower adsorbability to form a mature imitated embryonic plant (EB); third, the mature cystic EB is digested with 0.25 tryptic enzyme to 0.02 percent EDTA to a single cell, and then is inoculated to a tissue culture dish which is packed with I-shaped collagen in advance, solution culture is induced under the condition of dexamethasone and human trypsin, and the differentiation towards the liver cell direction is observed and judged. The prevent invention provides the method that the HES is efficiently divided into liver cells, at the same time, the method makes the follow-up judging work more simply and more efficient, and lay a foundation for the stem cellular transplantation or biologic artificial liver curing the disease such as serious hepatitis, hepatic failure and so on.
Owner:FIELD OPERATION BLOOD TRANSFUSION INST OF PLA SCI ACAD OF MILITARY

Induction factor for inducing differentiation of iPS (induced pluripotent stem) cells into cardiac muscle cells and application thereof

The invention belongs to the field of regenerative medicine of cardiac muscle tissues, and discloses application of ascorbic acid as an induction factor in inducting differentiation of iPS (induced pluripotent stem) cells into cardiac muscle cells and a differentiation-inducing culture medium containing ascorbic acid. The invention also discloses a method for inducing differentiation of iPS cells into cardiac muscle cells by using the differentiation-inducing culture medium, which comprises the following step: inducing an iPS cell derived embryoid body, which has grown in a suspension mode for 5-7 days, to differentiate by utilizing the differentiation-inducing culture medium, thereby obtaining cardiac muscle cells. By using ascorbic acid as the induction factor, the invention obviously enhances the differentiation efficiency of the iPS cells into the cardiac muscle cells, and the differentiation percentage can reach 50-60%; the differentiation-inducing culture medium does not have toxic or side effect on the cells; and in addition, the method provided by the invention is simple, has the advantage of low cost, can be operated in common laboratories, and is suitable for large-scale proceeding.
Owner:INST OF BASIC MEDICAL SCI ACAD OF MILITARY MEDICAL SCI OF PLA

Novel culture method for in vitro differentiation from human embryonic stem cells to functional myocardial cells

The invention discloses a novel culture method for in vitro differentiation from human embryonic stem cells to functional myocardial cells. The novel culture method is different from a conventional typical hanging-drop culture method. According to the novel culture method, an embryoid body is formed by adopting a simplified suspension differentiation culture method, serum-free culture liquid is adopted for improvement, and various inducing and nutrition-enriching substances are added into the culture liquid to increase the differentiation rate of the myocardial cells and prolong the survival time of the myocardial cells; a method for differentiation from embryonic stem cells to myocardial cells is further effectively updated and perfected, the proportion of the myocardial cells differentiated by the embryoid body is greatly increased, and a large quantity of myocardial cell sources with powerful functions can be provided for stem cell clinical transplantation treatment technology, drug screening and the like; the method is simple and feasible to carry out, the culture time is shortened, the functions for in vitro differentiation from the embryonic stem cells to the myocardial cells are improved and include pulsation time as well as autorhythmicity and rhythmicity of myocardial cell beating, and the method is good in repeatability.
Owner:奥思达干细胞有限公司

Method for differentiating human multipotential stem cells into hematopoietic stem cells and culture additive

The invention discloses a method for differentiating human multipotential stem cells into hematopoietic stem cells and a culture additive. The invention develops a culture solution capable of greatlyimproving the efficiency of differentiating human multipotential stem cells into hematopoietic stem cells. The invention also provides a novel method for differentiating human multipotential stem cells into hematopoietic stem cells. The hematopoietic stem cells can be obtained by adopting the preparation method provided by the invention, and compared with traditional matrix cell co-culture methodand embryoid body culture method, the doubly positive hematopoietic stem cells capable of expressing CD34 and CD343 can be efficiently obtained through the method, and the chemical components are definite and free of animal-derived components, so that the safety of cell preparation is greatly improved, and the method has the characteristics of low time consumption, high differentiation efficiency,relatively low cost and the like. The artificial hematopoietic stem cells can be produced in large scale by adopting the preparation method provided by the invention, the method is stable in qualityand high in safety, and a large number of cell sources are provided for tissue engineering, research and development of drugs and cell therapy.
Owner:TSINGHUA UNIV

Method for acquiring macrophages with phagocytic functions by means of pluripotent stem cell differentiation

The invention relates to the technical field of cell culture, and particularly provides a method for acquiring macrophages with phagocytic functions by means of pluripotent stem cell differentiation.Induced differentiation can be quickly and substantially carried out on cells of embryoid bodies by the aid of cell induced culture media to obtain the macrophages. First six culture media include serum-free culture media, basic nutrient substances which are required by growth, proliferation and differentiation of cells in various phases can be provided by the serum-free culture media, exogenous substances can be prevented, and accordingly pollution risks can be reduced. A seventh culture medium contains serum, FBS (fetal bovine serum) is additionally added into the seventh culture medium, andaccordingly growth of the macrophages can be effectively maintained. Each culture medium further contains diversified cell factors, and accordingly directional differentiation of the cells can be promoted. The method has the advantages that the method for carrying out induced culture on the cells is simple, is high in efficiency and low in cost and has important significance in clinical treatmentand research, and the high-quality and high-purity macrophages can be obtained in short periods by means of substantial amplification.
Owner:赛元生物科技(杭州)有限公司

Mice somatic cell nuclear transplantation method

The invention discloses an optimized mice somatic cell nuclear transplantation method. According to the mice somatic cell nuclear transplantation method, three kinds of cells, including cumulus cell, fetal fibroblasts, and embryonic stem cell, are adopted to construct reconstructed embryos; the activation efficiencies of three reconstructed embryos in different activation mediums are compared, development efficiencies in different solutions are compared, and pregnancy efficiencies of different embryo transplantation methods are compared; it is concluded that calcium-free KSOM activation medium is a universal high efficiency activation medium, and the activation efficiency is about 93.5%; KSOM-AA culture medium is suitable for in vitro culture of the reconstructed embryos of cumulus cells and embryonic stem cells, and the best culture medium for fetal fibroblasts is alpha MEM culture medium; when the reconstructed embryos are at 2-cell period, nuclear transplanted animals can be obtained via transplantation of embryos through bilateral fallopian tubes, wherein for each fallopian tube, transplantation of 15 embryos is carried out. The optimized mice somatic cell nuclear transplantation method is capable of increasing reconstructed embryo cleavage rate, blastula development rate, cloning animal birth rate, and survival rate, so that the success rate of obtaining embryonic stem cells from the reconstructed embryos is increased.
Owner:INNER MONGOLIA UNIVERSITY

Neural crest spectrum mesenchymal cell derived from pluripotent stem cells and induced differentiation method thereof

InactiveCN107858328AEnhanced CytologyIncreased therapeutic functionSkeletal/connective tissue cellsArtificially induced pluripotent cellsCell phenotypeCulture fluid
The invention discloses a neural crest spectrum mesenchymal stem cell derived from pluripotent stem cells and an induced differentiation method thereof. The induced differentiation method of the neural crest spectrum mesenchymal stem cell comprises the following steps: dissociating the pluripotent stem cells to obtain cell aggregates, carrying out suspension culture to form embryoid bodies, replacing a culture solution with a neural crest cell culture solution, carrying out suspension culture of the embryoid bodies, collecting the embryoid bodies and replacing the culture solution every day; enabling the embryoid bodies to grow for a certain time by adhering to the wall after culturing for a certain time; digesting and collecting cells; culturing the collected cells by enabling the cells to adhere to the wall, replacing the culture solution with a mesenchymal stem cell culture solution, carrying out passage culture, then detecting the mesenchymal cell phenotype to obtain the neural crest spectrum mesenchymal cell. Through the method, the defects of heterogeneity and hybridity between adult-derived mesenchymal stem cells and other mesenchymal stem cells derived from the pluripotentstem cells of non-finite induction pathways can be solved; the prepared neural crest spectrum mesenchymal stem cell has higher immunoregulation and osteogenic differentiation capabilities; the standardized induced differentiation process is capable of ensuring that cell populations prepared between different batches have good consistency.
Owner:广州赛隽生物科技有限公司

Method for differentiation of embryonic stem cells (ESC) into mesenchymal stem cells (MSC)

The invention discloses a method for differentiation of embryonic stem cells (ESC) into mesenchymal stem cells (MSC). The method comprises the following steps of 1, culturing ESC until a part of ESC trends a differentiation state so that fibrous cells are obtained, 2, digesting ESC obtained by the step 1 so that the adhesive fibrous cells are retained, 3, carrying out multiplication culture on the retained fibrous cells obtained by the step 2, and 4, digesting the fibrous cells obtained by the step 3, transferring the digested fibrous cells into an adhesive cell culture bottle and carrying out culture to obtain MSC. The method is free of embryo (EB) culture, realizes direct conversion of ESC into MSC and is simple. Compared with the method comprising direct digestion of ESC by pancreatin, then inoculation and MSC culture, the method provided by the invention has high MSC induction efficiency and short successful induction time.
Owner:ZHEJIANG UNIV

Method and culture media for inducing osteogenic differentiation of induced pluripotent stem cell of mouse

The invention discloses a method and culture media for inducing osteogenic differentiation of an induced pluripotent stem cell of a mouse. The method provided by the invention comprises the steps of inoculating the pluripotent stem cell of the mouse into a differentiation culture medium I to form an embryoid body with enriched mesenchymal cells, then separating the embryoid body and culturing in a differentiation culture medium II to obtain an osteoblast, wherein the differentiation culture medium I disclosed by the invention is formed by adding all-transretinoic acid and basic fibroblast growth factor on the basis of a fibroblast culture medium, and the differentiation culture medium II is formed by reducing the D-glucose content and adding BMP4 or BMP7 on the basis of an osteoblast culture medium. The method and the culture media provided by the invention can significantly promote the osteogenic differentiation of the pluripotent stem cell of the mouse, have the characteristics of short cycle, high differentiation rate, stable effect and the like, and have broad application prospect and practical value.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products